Carregant...
Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
SARS‐CoV‐2, a member of the coronavirus family, has caused a global public health emergency. Based on our analysis of hepatitis C virus and coronavirus replication, and the molecular structures and activities of viral inhibitors, we previously reasoned that the FDA‐approved hepatitis C drug EPCLUSA...
Guardat en:
| Publicat a: | Pharmacol Res Perspect |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7596664/ https://ncbi.nlm.nih.gov/pubmed/33124786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.674 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|